biostudies-literatureUnknown29(4)Nakagawara K<h4>Objectives</h4>We investigated the occurrence of non-respiratory bacterial and fungal secondary infections, causative organisms, impact on clinical outcomes, and association between the secondary pathogens and mortality in hospitalized patients with coronavirus disease 2019 (COVID-19).<h4>Methods</h4>This was a retrospective cohort study that included data from inpatients with COVID-19 from multiple centers participating in the Japan COVID-19 Taskforce (April 2020 to May 2021). We obtained demographic, epidemiological, and microbiological data throughout the course of hospitalization and analyzed the cases of COVID-19 complicated by non-respiratory bacterial infections.<h4>Results</h4>Of the 1914 patients included, non-respiratory bacterial infections with COVID-19 were diagnosed in 81Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy422-426https://www.ebi.ac.uk/biostudies/studies/S-EPMC9851919biostudies-literatureDiagnostic significance of secondary bacteremia in patients with COVID-19.PMC9851919Odani TNakamori YKawamura KMutoh YOno THosoda YYoshiyama TTanino YMashimo SWatase MWatanabe HOtsuki RKawana AAsakura TKamata HKumanogoh AKanai TKoike RKita TJapan COVID-19 Task ForceSaito FKimura AAmishima MSano HOgawa SNishi KKimura YLee HSato YNamkoong HKatayama KKimizuka YChubachi SMorita AMasuda MHashimoto SMiyano SAzekawa SIshikura HShoko THashimoto NKuwahara NIshii MOkamoto MTokunaga KKuramochi MAi MChihara YSato TMiyazawa NKono YNagasaki YTakaku YIshii TFukunaga KKusumoto TFujitani SKagaya TOtake SKusaka YAndo AShirai YTakano TOhba TTanaka HKitagawa YFukui MTsuchida TEdahiro RIshiguro THasegawa YAbe SMasaki KKasamatsu YFukushima TTakata TEndo AMori NTani MMurakami KHasegawa NMatsushita YMochimaru TImoto SHagiwara EKataoka KUeda SOgura SKitamura HUeda TFujiwara AHarada NKokutou HOkada YMiyawaki MOno HMuranaka HNakagawara KfalseDiagnostic significance of secondary bacteremia in patients with COVID-19.<h4>Objectives</h4>We investigated the occurrence of non-respiratory bacterial and fungal secondary infections, causative organisms, impact on clinical outcomes, and association between the secondary pathogens and mortality in hospitalized patients with coronavirus disease 2019 (COVID-19).<h4>Methods</h4>This was a retrospective cohort study that included data from inpatients with COVID-19 from multiple centers participating in the Japan COVID-19 Taskforce (April 2020 to May 2021). We obtained demographic, epidemiological, and microbiological data throughout the course of hospitalization and analyzed the cases of COVID-19 complicated by non-respiratory bacterial infections.<h4>Results</h4>Of the 1914 patients included, non-respiratory bacterial infections with COVID-19 were diagnosed in 812023-01-01T00:00:00Z2023 Apr2025-04-04T08:06:26.229Z2024-10-19T04:15:13.955ZS-EPMC98519193668260610.1016/j.jiac.2023.01.006